PROVIVE

This brand name is authorized in Brazil, Ecuador, Hong Kong SAR China, Lithuania, New Zealand, Nigeria, Poland, South Africa.

Active ingredients

The drug PROVIVE contains one active pharmaceutical ingredient (API):

1	Propofol UNII YI7VU623SF - PROPOFOL
	Propofol (2, 6-diisopropylphenol) is a short-acting general anaesthetic agent with a rapid onset of action of approximately 30 seconds.
	Read more about Propofol

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
PROVIVE Emulsion for injection	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N01AX10	Propofol	N Nervous system → N01 Anesthetics → N01A Anesthetics, general → N01AX Other general anesthetics
Discover more medicines within N01AX10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	533021090075217, 533021090075317, 533021090075417, 533021090075517, 533021090075617
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	500-MEE-1114
HK	Department of Health Drug Office	56205
LT	Valstybinė vaistų kontrolės tarnyba	1069923
NG	Registered Drug Product Database	04-7089
NZ	Medicines and Medical Devices Safety Authority	12524, 13986
PL	Rejestru Produktów Leczniczych	100215418, 100215424
ZA	Health Products Regulatory Authority	A39/2.1/0447